Omeprazole, antisecretory agents
Pharmaceutical preparation containing omeprazole together with an alkaline reacting compound or an alkaline salt of omeprazole optionally together with an ...
KI Lovgren，AG Pilbrant，M Yasumura，...
Development of an oral formulation of omeprazole
Omeprazole has a low water solubility and is chemically labile in an acid environment. In the formulation of an oral dosage form of omeprazole the possibil...
A Pilbrant，C Cederberg - 《Scandinavian Journal of Gastroenterology》
4716041 Diffusion coated multiple-units dosage form: Kim Kjornaes, Finn N Christensen, Jens R Jensen, Valby, Denmark assigned to A/S Alfred Benzon
Omeprazole has a low water solubility and is chemically labile in an acid environment. In the formulation of an oral dosage form of omeprazole the possibil...
- 《Biotechnology Advances》
New pharmaceutical preparation for oral use
Pharmaceutical preparation containing omeprazole together with an alkaline compound or an alkaline salt of omeprazole optionally together with an alkaline compound as the core material, one or more subcoating layers comprising inert reac...
Lvgren Kurt Ingmar，Pilbrant Ake Gunnar，Y Mitsuru，... - EP
CONTROL OF ACUTE ZOLLINGER-ELLISON SYNDROME WITH INTRAVENOUS OMEPRAZOLE
We report on the realization of a quantum degenerate atomic Fermi gas in an optical lattice. Fermi surfaces of noninteracting fermions are studied in a thr...
A Blanchi，JC Delchier，JC Soule，... - 《Lancet》
SUBSTITUTED PYRIDYLSULFINYLBENZIMIDAZOLES HAVING GASTRIC ACID SECRETION PROPERTIES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND INTERMEDIATES FOR THEIR PREPARATION
not available for EP000512of corresponding document:The present invention relates to novel compounds of the formula wherein R1 and R2 are the same or different and are each hydrogen, alkyl, halogen, carbomethoxy, carbethoxy, alkoxy, or a...
UK Junggren，SE Sjostrand - EP
Omeprazole salts
Novel salts of omeprazole with Li, Na, K, Mg, Ca2+, Ti, N(R)as cation; processes for their preparation thereof, pharmaceutical compositions containing such salts and their use in medicine.
Brndstrm Arne Elof
Diffusion coated multiple-units dosage form
By subjecting the thus coated units to heating to accelerate the formation of a continuous phase of the film-forming agent of the inner layer and optionall...
FN Christensen，JR Jensen，K Kjornaes - US
PHARMACEUTICAL PREPARATION FOR ORAL USE
1. Pharmaceutical preparation for oral use, comprising as a biologically active material N-methylglucamine salt of acridone-acetic acid, target additives and enteric-soluble cover, characterized in that it further comprises as an additiv...
ALEKSEYEVA, LUDMILA, EVGENYEVNA，KOVALENKO, ALEKSEY, LEONIDOVICH
Diffusion coated multiple-units dosage form
In an oral pharmaceutical controlled release multiple-units formulation, individual units containing an active substance are coated with a substantially water-insoluble, but water-diffusible controlled release coating which includes
K Kim，Linnemann Jorgen - US
